Axiom Investors LLC Castle Biosciences Inc Transaction History

Axiom Investors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$60.13 - $77.6 $1.88 Million - $2.43 Million	-31,310 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$50.07 - $76.78 $869,715 - $1.33 Million	-17,370 Reduced 35.68%	31,310 $2.3 Million
Q1 2021 May 14, 2021	SELL	$58.92 - $97.33 $538,823 - $890,082	-9,145 Reduced 15.81%	48,680 $3.33 Million
Q4 2020 Feb 12, 2021	BUY	$43.6 - $73.05 $2.52 Million - $4.22 Million	57,825 New	57,825 $3.88 Million

202

26M

303K

30.3K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $739M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Axiom Investors LLC , based on Form 13F filings with the SEC.

Stay updated on Axiom Investors LLC with notifications on news.